E45 ITCH RELIEF CREAM
Active substance(s): LAUROMACROGOLS / UREA
NAME OF THE MEDICINAL PRODUCT
E45 Itch Relief Cream
QUALITATIVE AND QUANTITATIVE COMPOSITION
For the treatment of pruritus, eczema, dermatitis, and scaling skin conditions
where an antipruritic and/or hydrating effect is required. It may also be used
for the continued treatment and follow-up treatment of these skin diseases.
Posology and method of administration
Adults, the elderly, children and infants over the age of 1 month: E45 Itch Relief
Cream should be applied to each affected area twice a day. The duration of treatment
depends on the clinical response.
Patients with known hypersensitivity to any of the ingredients. It should not be
used to treat acute erythroderma, acute inflammatory, oozing or infected skin
Special warnings and precautions for use
E45 Itch Relief Cream may cause irritation if applied to broken or inflamed
Interactions with other Medicinal products and other forms of interaction
Pregnancy and lactation
There are no specific restrictions concerning its use during pregnancy, but it is
not to be used on the breasts immediately prior to breast feeding during
Effects on ability to drive and use machines
E45 Itch Relief Cream has been reported to cause a burning sensation,
erythema, pruritus or the formation of pustules. Contact allergy has also been
Urea is a physiological product derived from human protein metabolism. It is
found naturally in the skin and when applied topically it can increase the horny
layer’s capacity to retain water. E45 Itch Relief Cream has been shown to
increase skin hydration and when used as recommended provides hydration
for 24 hours. Patients with eczema and psoriasis have been shown to have
decreased levels of urea in their skin. Urea is not allergenic and is welltolerated at a concentration of 5%.
Lauromacrogols have the properties of a topical anaesthetic and have an
antipruritic effect. The local tolerability of lauromacrogols is good.
E45 Itch Relief Cream has also been shown to increase the lipid content of the
epidermis thus, soothing and smoothing the skin.
Little urea is absorbed after topical application. It is mainly excreted in the
urine, and to a lesser extent in perspiration.
There is no evidence of systemic availability of lauromacrogols after topical
Preclinical safety data
No specific studies have been performed with E45 Itch Relief Cream. Urea
and lauromacrogols have been used therapeutically for many years in humans.
Information from animal studies are unlikely to provide any further relevant
List of excipients
Dimeticone, phenyl dimeticone, liquid paraffin, cetyl palmitate, stearic
palmitic acid, octyldodecanol, glycerol 85%, polysorbate, carbomer,
trometamol, benzyl alcohol, purified water.
Special precautions for storage
Do not store above 25°C.
Nature and contents of container
Aluminium tubes with double internal lacquer of epoxy phenol resin and closure
made of polyoxyethylene. Content: 10g, 35g, 50g, 60g, 75g, 100g and 110g.
Plastic pump dispensers. Content: 175g, 200g and 500g.
A pump pack, made of polypropylene and polyethylene, consisting of a piston
pump system with an airless dispenser. Pack size: 500g
Not all pack sizes are necessarily marketed.
Instruction for use and handling
MARKETING AUTHORISATION HOLDER
Crookes Healthcare Limited
Trading as Crookes Healthcare
1 Thane Road West
MARKETING AUTHORISATION NUMBER
DATE OF FIRST AUTHORISATION/RENEWAL OF THE
19 October 1999
DATE OF REVISION OF THE TEXT